Gill Farrar Selected Research

Alzheimer Disease (Alzheimer's Disease)

4/2024	Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
3/2024	Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
3/2024	Quantitative Brain Amyloid PET.
11/2023	Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification.
5/2023	Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment.
1/2023	Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.
1/2023	Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
12/2022	Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease.
1/2022	Quantification of amyloid PET for future clinical use: a state-of-the-art review.
1/2022	The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gill Farrar Research Topics

Disease

29	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2007
14	Dementia (Dementias) 04/2024 - 12/2016
12	Cognitive Dysfunction 03/2024 - 09/2010
10	Amyloid Plaque 06/2023 - 12/2012
5	Death (Near-Death Experience) 11/2020 - 12/2016
2	Amyloidosis 06/2023 - 12/2012
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2019 - 12/2016
2	Atrophy 01/2018 - 12/2016
2	Normal Pressure Hydrocephalus 01/2014 - 12/2012
2	Thrombosis (Thrombus) 04/2007 - 01/2007
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2007 - 01/2007
2	Venous Thromboembolism 01/2007 - 07/2006
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Neuroinflammatory Diseases 01/2021
1	Gliosis 01/2021
1	Disease Progression 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016
1	Pulmonary Embolism 01/2007
1	Thromboembolism 07/2006

Drug/Important Bio-Agent (IBA)

34	Amyloid (Amyloid Fibrils)IBA 04/2024 - 09/2010
20	flutemetamolIBA 04/2024 - 11/2012
4	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 03/2024 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2007
2	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 04/2024 - 03/2024
2	florbetapirIBA 04/2024 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2018
2	Peptides (Polypeptides)IBA 01/2020 - 11/2019
2	Amyloid beta-PeptidesIBA 11/2012 - 02/2007
2	99mTc-NC100668IBA 01/2007 - 07/2006
1	Prealbumin (Transthyretin)IBA 06/2023
1	formic acid (formate)IBA 06/2023
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	verubecestatIBA 12/2022
1	Apolipoproteins E (ApoE)IBA 01/2021
1	NeurograninIBA 01/2021
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2012
1	SilverIBA 12/2012
1	Coloring Agents (Dyes)IBA 12/2012
1	AD 20 (AD-20)IBA 09/2010
1	acetyl- Asn- Gln- Glu- Gln- Val- Ser- Pro- Tyr(3- iodo)- Thr- Leu- Leu- Lys- Gly- NC100194IBA 04/2007
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2007
1	Thrombin FDA Link 01/2007
1	AnticoagulantsIBA 01/2007
1	A-factor (Streptomyces)IBA 01/2007
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2007
1	seryl-prolineIBA 07/2006
1	RadiopharmaceuticalsIBA 07/2006
1	leucylleucine (Leu-Leu)IBA 07/2006
1	lysylglycineIBA 07/2006

Therapy/Procedure

1	Intravenous Administration 06/2019
1	Thrombolytic Therapy 01/2007